Recombinant Protein Drugs: A 2025 Update. - López-Laguna H; Parladé E; Favaro MTP; Palacín C; Voltà-Durán E; Ferrer-Miralles N; Corchero JL; Rodríguez-Rodríguez R; Vázquez E; Unzueta U; Villaverde A (BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2026)